Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach.
about
Clinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophyThe clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophyVaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophyThe Vulvovaginal Symptoms Questionnaire: a questionnaire for measuring vulvovaginal symptoms in postmenopausal womenA Practical Solution for Dyspareunia in Breast Cancer Survivors: A Randomized Controlled TrialImpact of vulvovaginal atrophy on sexual health and quality of life at postmenopause.Assessment of vaginal atrophy: a review.Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society.Monurelle Biogel(®) vaginal gel in the treatment of vaginal dryness in postmenopausal women.Newly developed vaginal atrophy symptoms II and vaginal pH: a better correlation in vaginal atrophy?The efficacy and safety of estriol to treat vulvovaginal atrophy in postmenopausal women: a systematic literature review.Microablative fractional CO2 laser for the genitourinary syndrome of menopause: power of 30 or 40 W?Randomized, Double-Blind, Placebo-Controlled Study of Modified Erzhi Granules in the Treatment of Menopause-Related Vulvovaginal Atrophy
P2860
Q28066699-27E71E11-D9C6-4F05-ABED-6A8C234295E8Q35626394-19DF32FD-BAF9-46CB-8A32-61FD051B6A6EQ35647630-2BC5955E-0599-4D1D-B7EA-458B91483497Q35772337-CC09341C-B72B-4E11-823C-95253260F0E6Q36482360-564C49E1-E553-4D1D-911E-BD95A5974183Q36962161-35F672F8-002A-46E4-B2C5-C676D859FCAFQ37164132-039A82ED-ACBE-4170-A1E8-12837DD39552Q38178431-64BF5E51-907E-4CC1-8046-E348447601F6Q38232359-BDC28A4C-0D6E-44E5-938F-A5F439046DDAQ38242862-1B514210-C6DD-4BD6-BF4A-28A58D9AC6DFQ38374840-76419484-2D74-4FD8-A4A1-DFC65762D339Q39102524-28A11341-9989-4271-86F5-DA5ECCEA1CD3Q39378397-C7199EB9-06E4-4516-95C1-A85ADFB297D4Q40108790-5F2B01ED-C45C-4780-B868-1930D2A279F2Q58567402-CF589A21-EEB7-4D52-BE8E-6E93455DF5B5
P2860
Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Measuring symptom relief in st ...... t bothersome symptom approach.
@en
Measuring symptom relief in st ...... t bothersome symptom approach.
@nl
type
label
Measuring symptom relief in st ...... t bothersome symptom approach.
@en
Measuring symptom relief in st ...... t bothersome symptom approach.
@nl
prefLabel
Measuring symptom relief in st ...... t bothersome symptom approach.
@en
Measuring symptom relief in st ...... t bothersome symptom approach.
@nl
P2093
P1433
P1476
Measuring symptom relief in st ...... t bothersome symptom approach.
@en
P2093
Bruce Ettinger
Haibin Shu
Howard Hait
Kathleen Z Reape
P304
P356
10.1097/GME.0B013E318182F84B
P407
P577
2008-09-01T00:00:00Z